Detail of > 8076-65-1
- CAS Number:
- 8076-65-1
- Name:
Magnesium potassium aspartate
- Formula:
- C8H11KMgN2O8.C4H6KNO4
- Molecular Structure:

- Synonyms:
- Asparkam;DL-Aspartic acid, monopotassium salt, mixt. with potassium hydrogen (T-4)-bis(DL-aspartato(2-)-N,O1)magnesate(2-);Potassium magnesium hydrogen DL-aspartate;DL-Aspartic acid, monopotassium salt, mixt. with potassium hydrogen (T-4)-bis(DL-aspartato(2-)-N,O(sup 1))magnesate (2-);Tromcardin;Aspartic acid, monopotassium salt, mixt. with potassium hydrogen (T-4)-bis(aspartato(2-)-kappaN,kappaO1)magnesate(2-);dipotassium; 2-aminobutanedioate; 2-amino-4-hydroxy-4-oxo-butanoate; magnesium(+2) cation;DL-Aspartic acid, magnesium potassium salt;Aspartic acid,monopotassium salt,mixt. with potassium hydrogen (T-4)-bis[aspartato(2-)-kN,kO1]magnesate(2-);Panangin;DL-Aspartate Magnesium Potassium;
- Molecular Weight:
- 497.78
- Boiling Point:
- 264.1 °C at 760 mmHg
- Flash Point:
- 113.5 °C
Related products
- 67528-13-6Potassium Magnesium L-Aspartate
- 8076-65-1Magnesium potassium aspartate
- 72231-13-1Magnesium Aspartate
- 62601-48-3High activity potassium fluoride
- 14007-45-5L-Asparticacid, potassium salt (1:?)
- 83270-50-2D-Galactose, polymer with butanedioic acid and D-glucose, 2-oxopropanoate, ammonium calcium magnesium potassium sodium salt
- 2068-80-6L-Aspartic acid,magnesium salt (2:1)
- 9000-97-9Aminotransferase,aspartate
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 8076-65-1Magnesium potassium aspartate
- 1491-41-41H-Benz[de]isoquinoline-1,3(2H)-dione,2-[(diethoxyphosphinyl)oxy]-
- 1009-36-5Benzene,1-chloro-2-methoxy-4-nitro-
- 8014-09-3Oils, patchouli
- 507-55-1Propane,1,3-dichloro-1,1,2,2,3-pentafluoro-
- 80471-63-2Androst-2-ene-2-carbonitrile,4,5-epoxy-3,17-dihydroxy-4,17-dimethyl-, (4a,5a,17b)-
- 68498-25-93H-Imidazo[2,1-i]purine,3-(2-deoxy-b-D-erythro-pentofuranosyl)-
- 12715-61-6Cobaltate(2-),bis[2-[2-[5-(aminosulfonyl)-2-(hydroxy-kO)phenyl]diazenyl-kN1]-3-(oxo-kO)-N-phenylbutanamidato(2-)]-, hydrogen (1:2)
- 1318-16-7Bauxite
- 2758-06-7Ethanaminium,2-bromo-N,N,N-trimethyl-, bromide (1:1)
- 87996-55-2Methanone,(4-chlorophenyl)[4-(trifluoromethoxy)phenyl]-
- 13558-31-1Xanthylium,3,6-diamino-9-(2-carboxyphenyl)-, chloride (1:1)
- 1093-58-9Androst-4-en-3-one,4-chloro-17-hydroxy-, (17b)-
- 61789-81-9Quaternary ammoniumcompounds, bis(hydrogenated tallow alkyl)dimethyl, Me sulfates
- 60-10-6Diazenecarbothioicacid, 2-phenyl-, 2-phenylhydrazide
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(5)
India(2)
- Business Type:
- Importer/Exporter(5)
- Certificates:
- ISO (0) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Correction of the acid-base equilibrium as one of the treatment factors in dust diseases
- Correction of the acid-base equilibrium as one of the treatment factors in dust diseases. Nargizyan, G. A.; Avakyan, M. A.; Melik-Israelyan, S. S. (USSR). Zh. Eksp. Klin. Med., 16(2), 82-7 (Russian) 1976. CODEN: ZKMAAX. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Acid-base equil. was disturbed in workers of mining and construction materials industries. A correlation was found between blood pCO2 and pH and between blood enzymic activity, including alanine transaminase [9000-86-6] and lactate dehydrogenase [9001-60-9], as well as blood pyruvic acid [127-17-3] and lactic acid [50-21-5] levels. Applications of the broncholytic derivs. euphyllin [317-34-0], novodrin [299-95-6], and euspiran [7683-59-2] normalized respiratory acidosis and improved the function of external respiration.In this experiment, several chemicals are used like 317-34-0 and 299-95-6 KCl and panangin [8076-65-1] normalized metabolic alkalosis. Thus, treatment with drugs normalizing the acid-base equil. increases the efficiency of the overall treatment of lung dust diseases. .
- Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction
- Effect of potassium and magnesium aspartate on experimental myocardial ischemia and infarction. Jiang, Xierong; Chen, Weiping; Shi, Hualian; Zhou, Lianfa (Tianjin Inst. Mater. Med.There are some reagents with their cas registry numbers 18962-61-3 and 14007-45-5 are used in this study., Tianjin 300070, Peop. Rep. China). Zhongguo Yaoli Xuebao, 5(1), 36-9 (Chinese) 1984. CODEN: CYLPDN. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) K magnesium aspartate [8076-65-1] was as effective as propranolol in decreasing the size of myocardial infarctions in cats. Comparison of the individual salts of aspartate indicated that magnesium aspartate [18962-61-3] may enhance the beneficial effect of K aspartate [14007-45-5] on myocardial ischemia. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

